Researchers of this study evaluated the bioequivalence of once-daily and twice-daily formulations of deutetrabenazine in a randomized crossover trial involving 262 healthy adults.

Read More > https://tardivedyskinesia.pocn.com/treatment/study-compares-efficacy-of-once-daily-and-twice-daily-deutetrabenazine/